Press release
Illumina, Inc. (NASDAQ:ILMN) Investor Lawsuit over alleged Failure to Maximize Shareholder Value filed
A lawsuit was filed by an investor in NASDAQ:ILMN shares in connection with the takeover offer for Illumina, Inc and NASDAQ:ILMN stockholders should contact the Shareholders Foundation.San Diego, CA, USA (February 06, 2012) -- The Shareholders Foundation announces that an investor in shares of Illumina, Inc. (NASDAQ:ILMN) filed a lawsuit in State Court against the members of Illumina's board of directors arising out of their alleged breaches of fiduciary duty related to their alleged self-interested and unreasonable responses to a premium, non-coercive buyout offer for Illumina made by Roche Holdings Ltd.
Investors who purchased Illumina, Inc. (NASDAQ:ILMN) shares prior to January 24, 2012, have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.
On January 3, 2012, Roche made a private, formal offer of $40.00 per share. Rather than considering Roche's efforts and non-coercive offer in good faith, the defendants rejected it out of hand, so the plaintiff.
Then on January 25, 2012, Roche publicized that it is proposing to acquire all outstanding shares of Illumina, Inc. (ILMN) for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis. But on January 26, 2012, Illumina, Inc. (ILMN) already announced that its Board of Directors adopted a Rights Agreement also known as a poison pill that allows to deflect offers for the company.
The plaintiff alleges that defendants refused to consider Roche's premium, non-coercive offer in good faith and the board’s refusal to make any attempt to negotiate a higher price demonstrates the perpetual nature of the excuses being offered up by the defendants to cover up their true motive for rebuffing Roche.
Those who are current investors in Illumina, Inc. (Public, NASDAQ:ILMN) shares, have certain options and should contact the Shareholders Foundation.
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact:
Jacob Rosenfeld
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail(at)shareholdersfoundation.com
Web: http://www.shareholdersfoundation.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Illumina, Inc. (NASDAQ:ILMN) Investor Lawsuit over alleged Failure to Maximize Shareholder Value filed here
News-ID: 209863 • Views: …
More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…

Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc.
Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation…

Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc.
Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: RXST…

Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc.
Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Illumina
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf
HTF MI just released the Global Microarray Biochips Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Microarray Biochips Market are: Thermo Fisher Scientific,…
Metagenomics Market: Gaining Unprecedented Momentum | Illumina, PerkinElmer
IMR posted new studies guide on Metagenomics Market Insights with self-defined Tables and charts in presentable format. In the Study you may locate new evolving Trends, Drivers, Restraints, Opportunities generated via targeting market related stakeholders. The boom of the Metagenomics marketplace became specifically driven with the aid of the growing R&D spending internationally.
Metagenomics Market Size Was Valued at USD 2.05 Billion in 2023, and is Projected to Reach USD 6.31…
Bioinformatics Market: Know Opportunity Ahead | Illumina, QIAGEN, Wuxi NextCODE
The latest study released on the Global Bioinformatics Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Bioinformatics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Agrigenomics Market is Booming Worldwide | Illumina, LGC, Eurofins USA
Advance Market Analytics added research publication document on Worldwide Agrigenomics Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Agrigenomics market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2023 which is estimated and forecasted till 2028*. Some are the…
Biochips Market Emerging Trends, Size, Share, Growth may Make Driving Growth Vol …
Biochips Market Analysis Report is structured with the meticulous efforts of an innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. This report also offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. Biochips Market analyses the industry based on different factors like growth trends, consumer volume, and market size, demand…
Biochips Market Share 2020-26, Illumina, PerkinElmer, QIAGEN
The latest study on the Global Biochips market report represents a deep appraisal of the international industry. The research report on the worldwide Biochips market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Biochips industry status and authorized projection related to the Biochips market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also offers an in-depth overview…